CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 160 enrolled
Drug / intervention
Baseline Geriatric Screening/Assessment +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02359838
NCT02359838N/ACompleted
CompareCT.gov

Patient-Centered Care for the Older Adult With Hematologic Malignancy

Dana-Farber Cancer Institute·interventional·Posted Feb 10, 2015·Updated Jul 19, 2022

In Brief

A clinical study evaluating Baseline Geriatric Screening/Assessment and Geriatrician Co-Management for Hematologic Malignancy. Completed, enrolled 160 participants across 1 site.

Detailed Summary

This research study is evaluating if co-management by a geriatrician embedded in the oncology clinic can improve outcomes for frail older adults with blood cancers. A rigorous pre-entry frailty assessment by a trained research assistant will be followed by randomization to geriatrician co-management versus usual care for patients found to be frail or pre-frail.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHematologic Malignancy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 10, 2015
Enrollment StartFeb 1, 2015
Primary CompletionMay 1, 2018
Study CompletionMay 1, 2020
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 11.4 years ago

Interventions

Baseline Geriatric Screening/Assessmentother

All patients receive baseline geriatric screening/assessment by a research assistant to determine frailty status.

Geriatrician Co-Managementother

A board-certified geriatrician embedded in the oncology clinic will co-manage patients randomized to this arm.